drug · protein

F-652

Phase 2updated 3mo ago

by Evive Biotech🔗 ChEMBL

Phase 2

community read0 votes

Protein drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.

targets

IL22 Receptor

all catalysts(0)

nothing on the calendar yet

Trials studying F-652

phase2Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19terminatedn=1
phase2Study of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) Pneumoniawithdrawn

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · protein

save

F-652

Phase 2updated 3mo ago

by Evive Biotech🔗 ChEMBL

Phase 2

community read0 votes

Protein drug with a maximum clinical stage of Phase 2 (across all indications), with 3 investigational indications.

targets

IL22 Receptor

all catalysts(0)

nothing on the calendar yet

Trials studying F-652

phase2Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19terminatedn=1
phase2Study of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) Pneumoniawithdrawn

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

F-652

targets

all catalysts(0)

Trials studying F-652

News(0)

Report a data issue

comments(0)

F-652

targets

all catalysts(0)

Trials studying F-652

News(0)

Report a data issue

comments(0)